Demand Science is a global buyer intelligence platform that accelerates demand generation for the world’s largest software, technology, and B2B companies. Leveraging decades of experience in B2B market intelligence, analytics, content trends, and predictive intent, Demand Science delivers healthy data and prioritized buyer insights that align sales and marketing professionals with more qualified audiences through its PureB2B, Klarity, Internal Results, Leadiro, Tidings, and BIOMES brands.
Xtalic works with industry-leading companies to find solutions to ensure durability and performance of their products as it relates to electrical connectivity. Through research and development, the Company has created three proprietary alloys that remove the need for and/or reduces the amount of precious metals typically founded in electrical connectors. Xtalic’s alloys increase the wear capabilities of the connector by removing the need for nickel, a softer metal, allowing for greater product longevity. MCRC’s investment was done in conjunction with an equity injection from existing investors, Matrix Partners and North Bridge Venture Partners.
Founded in 2010 and headquartered in Boston, MA, Promoboxx is a digital marketing platform that helps businesses to connect with their local retailers to promote their brand and products. The platform enables brands to create and distribute marketing content to their retailers and also provides tools to measure the effectiveness of the campaigns. Promoboxx has worked with over 200 leading worldwide brands. The investment proceeds will support the Company’s growth and product development.
Founded in 2009 and based in Woburn, MA, Emphysys is a technology and product development firm with specialties in medical devices, semiconductor equipment, and industrial equipment. The Company partners with customers varying from start-ups to multi-billion-dollar corporations, leveraging their engineering expertise, to help provide design services for next generation products. MCRC is in participation in a preferred equity investment led by Valero Capital to purchase a minority ownership stake in Emphysys, Inc.
Founded in 1996 and located just outside of Boston, Full Spectrum Software is a highly specialized software engineering firm providing cutting-edge, innovative software solutions for Medical Devices, Life Sciences, Robotics, Artificial Intelligence, the Internet of Things, and Digital Health. With experience spanning over 23 years and developing over 450 commercial products and systems, Full Spectrum brings top-level expertise and efficiency to any product development. Full Spectrum has been ISO 13485 certified since 2009 and has expertise in IEC 61508, IEC 62304, IEC 60601, and other standards. Full Spectrum is also a proud Microsoft Certified Gold Partner and Apple Solutions Developer. MCRC provided subordinated debt and preferred equity alongside co-investors, Pine Street Capital Partners, and Valero Capital.